Bio-Techne Corp
F:TE1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bio-Techne Corp
F:TE1
|
US |
|
Brookfield Corp
NYSE:BN
|
CA |
|
A
|
Airbus SE
F:AIR
|
NL |
|
Kering SA
F:PPXB
|
FR |
|
F
|
Fortune Brands Home & Security Inc
F:2FB
|
US |
|
A
|
Alphabet Inc
F:ABEC
|
US |
|
T
|
Toll Brothers Inc
F:TLK
|
US |
|
F
|
First Citizens BancShares Inc (Delaware)
F:FC6A
|
US |
Wall St Price Targets
TE1 Price Targets Summary
Bio-Techne Corp
According to Wall Street analysts, the average 1-year price target for
TE1 is 56.03 EUR with a low forecast of 39.58 EUR and a high forecast of 65.01 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TE1's stock price target?
Price Target
56.03
EUR
According to Wall Street analysts, the average 1-year price target for
TE1 is 56.03 EUR with a low forecast of 39.58 EUR and a high forecast of 65.01 EUR.
What is the Revenue forecast for Bio-Techne Corp?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 6%.
What is the Gross Profit forecast for Bio-Techne Corp?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 5 years is 7%.
What is the Operating Income forecast for Bio-Techne Corp?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 5 years is 16%.
What is the Pre-Tax Income forecast for Bio-Techne Corp?
Projected CAGR
68%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -4%. The projected CAGR for the next 3 years is 68%.
What is the Net Income forecast for Bio-Techne Corp?
Projected CAGR
43%
Over the last 13 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 5 years is 43%.